5 Years Ago!
You have to understand that Pharma corporations are not allowed to patent a natural plant so must synthesize the natural ingredient that works to make money. Your life means nothing to them but what's in your wallet does. End of story...
In 2014 news spread about a miracle berry extract called EBC-46, sourced from the Australian rainforest, that has been shown to cure various types of cancers including breast and prostate in humans and animals.
The Daily Mail reported:
‘Scientists at QIMR Berghofer Medical Research Institute in Queensland have used an experimental drug produced from the seeds of the rainforest plant, Blushwood tree (Hylandia Dockrillii), which exclusively grows in far north Queensland, to cure solid cancer tumours in pre-clinical trials.
Already the drug has been used to successfully destroy or shrink tumours in pets and animals – including dogs, cats and horses and even Tasmanian Devils, while human trials are imminent.’
These results were discovered in an eight-year study led by Dr. Glen Boyle, from the QIMR Berghofer medical research institute in Brisbane. In 75% of cases, the cancer never returns. There were no side effects, and the compounds started working in five minutes, making cancerous melanoma and neck tumors disappear in a matter of days.
Then for 2 years nothing much happened? Why?
First lets look at what this ‘drug’ really is:
This is from an article published by Cairns News in 2014:
“It’s a small molecule that actually works with the body to destroy cancer, rather than being a chemo-therapy approach which is acting, in many cases, against the body,” Q-Biotics CEO Victoria Gordon told Nine this week.
Q-Biotics are the company behind this discovery and are now looking to create a drug based treatment out of this:
This is from their website:
QBiotics is an Australian public unlisted life sciences company. We are in the business of development and commercialisation of pharmaceutical products that have the potential to address major health problems for humans and companion animals (dogs, cats and horses). Our products are new chemical entities which we source from Australia’s pristine tropical rainforests.
You can see their video presentation about EBC-46 here https://qbiotics.com/
‘Tigilanol tiglate (USAN), previously known as EBC-46 is an experimental drug candidate being studied pre-clinically by the Australian company Ecobiotics (specifically its drug discovery subsidiary Qbiotics). It was discovered through an automated screening process of natural products by selecting increasingly purified fractions of plant extracts, based on their ability to produce the desired activity profile. This is then followed by artificial synthesis of the isolated compound to confirm its chemical structure. EBC-46 is a phorbol ester which, along with other related compounds, acts as a protein kinase C regulator.
